Smoore International Holdings Limited has approved the issuance of 1.93 million share options to 10 employees under its Amended Share Option Scheme, according to a board announcement dated 16 April 2026.

Key terms of the grant • Exercise price: HK$9.42 per share, matching the stock’s 16 April 2026 closing price and exceeding the five-day average of HK$9.37 as well as the US$0.01 par value. • Vesting schedule: Options vest in eight tranches between 16 April 2027 and 30 April 2030, tied to individual performance ratings. • Exercise window: Vested options may be exercised any time until 15 April 2036; unexercised options lapse thereafter. • Consideration and clawback: Each grantee pays HK$1 on acceptance, and options lapse if employment terminates, in line with the plan’s clawback provisions.

Compliance details The company confirmed that none of the grantees is a director, chief executive, substantial shareholder, related-entity participant or service provider whose awards breach individual limits under Listing Rule 17.03D(1). No financial assistance has been provided for share purchases.

Mandate capacity Following the grant, 549.09 million shares remain available under the combined 10% Scheme Mandate Limit covering both the Amended Share Option Scheme and the Amended Share Award Scheme. Assuming all outstanding share-award obligations are met through new share issuance, 544.33 million shares would still be unallocated.

Board composition The board currently comprises four executive directors, one non-executive director and three independent non-executive directors, chaired by Mr. Chen Zhiping.

The share-option grant supports Smoore International’s long-term incentive framework while preserving substantial headroom under its existing mandate limits.